MRK DCF Analysis: Intrinsic Value $43 vs Price $146

gurufocus.com · 2026-10-19

On October 19, 2026, we conducted a DCF analysis for Merck & Co Inc (MRK), a company that has shown impressive price performance over the past year, with a 79.0

TickrTrends take: According to DCF analysis, MRK's intrinsic value is estimated at $43 per share while the stock trades at $146, representing a significant gap between calculated fundamental value and current market price. This valuation gap aligns with TickrTrends' current assessment that MRK is overvalued within the Healthcare sector. Investors focused on valuation metrics should monitor whether the stock price adjusts toward fundamental value estimates or whether market conditions and company performance may support the current premium over DCF-derived intrinsic value.

Read the full story at gurufocus.com →